Mangoceuticals (MGRX) Accumulated Expenses (2022 - 2026)

Mangoceuticals' Accumulated Expenses history runs 5 years deep, the most recent figure standing at $3297.0 for Q1 2026.

• In Q1 2026, Accumulated Expenses changed N/A year-over-year to $3297.0; the TTM figure through Mar 2026 stood at $3297.0 (changed N/A YoY), while the FY2025 annual figure was $9421.0, changed N/A from the prior year.
• Accumulated Expenses came in at $3297.0 for Q1 2026 at Mangoceuticals, down from $9421.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $9421.0 in Q4 2025 to a low of $2717.0 in Q4 2022.
• A 5-year average of $5556.8 and a median of $5133.5 in 2024 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses soared 142.73% in 2023 and plunged 36.57% in 2025, its largest moves.
• Mangoceuticals' Accumulated Expenses stood at $2717.0 in 2022, then jumped by 142.73% to $6595.0 in 2023, then fell by 15.39% to $5580.0 in 2024, then jumped by 68.84% to $9421.0 in 2025, then sank by 65.0% to $3297.0 in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $3297.0, $9421.0, and $4460.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison